Sphingolipid Signaling Pathways as Potential Therapeutic Targets in Gliomas

Author(s): James R. Van Brocklyn

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 7 , Issue 10 , 2007

Become EABM
Become Reviewer
Call for Editor


Glioblastoma multiforme (GBM) is a highly malignant brain tumor. The interconvertible bioactive sphingolipids sphingosine-1-phosphate (S1P) and ceramide have profound effects on GBM cells, with ceramide causing cell death and S1P leading to cell survival, proliferation and invasion. This review will examine the effects of ceramide and S1P on glioma cells and the therapeutic potential of these pathways.

Keywords: Glioma, glioblastoma multiforme, sphingolipids, sphingosine-1-phosphate, ceramide

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Published on: 01 March, 2012
Page: [984 - 990]
Pages: 7
DOI: 10.2174/138955707782110123
Price: $65

Article Metrics

PDF: 12